Johnson & Johnson (JNJ)
| Company | Ticker | Sector | Industry | Quality | PAR |
|---|---|---|---|---|
| Johnson & Johnson | JNJ | Healthcare | Drug Manufacturers (Major) | 90 | 5.4% |
| Current Price (01/21) | $149.27 | |||
| CAPS Rating (Rate this stock on CAPS) |  |
|||
| Expected Income Statement | ||||
| Current Sales | 82,139.2 | |||
| Sales Growth Forecast | 4.2% | |||
| Net Profit Margin | 29.7% | |||
| Projected Shares Outstanding | 2,589.29 | |||
| EPS - Five year Forecast | $11.56 | |||
| Average P/E Ratio | 15.0 | |||
| Projected Average Price | $173.45 | |||
| Price Appreciation (Annualized) | 3.0% | |||
| Annual Dividend Yield | 2.4% | |||
| Projected Annual Return | 5.4% | |||
| Quality | ||||
| Financial Strength | 99 | 24.9 | ||
| EPS Stability | 88 | 22.1 | ||
| Industry Sales Growth Rate | 8.0% | 6.5 | ||
| Industry Net Profit Margin | 22.5% | 16.5 | ||
| Calculated Quality Rating | 70.0 | |||
| Fool CAPS | ||||
Total Players
13572
Outperforms
508
Underperforms
All-Stars (2969)
2899
Outperforms (98%)
70
Underperforms
|
||||
| Fundamental Data Updated: 11/15/2019 | ||||